Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M Monami, N Marchionni… - European journal of …, 2009 - academic.oup.com
Objective The role of glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of
type 2 diabetes is debated; many recent trials, which were not included in previous meta …
被引用次数：182 相关文章
[HTML] nih.gov

[HTML][HTML] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M Monami, N Marchionni… - Database of Abstracts of …, 2009 - ncbi.nlm.nih.gov
The review concluded that the prophylactic use of glucagon-like peptide-1 receptor agonists
for type 2 diabetes effectively reduced glycosylated haemoglobin and postprandial glucose; …

[引用][C] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.

M Monami, N Marchionni, E Mannucci - EUROPEAN JOURNAL OF …, 2009 - flore.unifi.it
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized
clinical trials/Monami M; Marchionni N; Mannucci E.-In: EUROPEAN JOURNAL OF …

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M Monami, N Marchionni… - European journal of …, 2009 - pubmed.ncbi.nlm.nih.gov
Objective The role of glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of
type 2 diabetes is debated; many recent trials, which were not included in previous meta …

[引用][C] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M MONAMI, N MARCHIONNI… - European journal of …, 2009 - pascal-francis.inist.fr
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of
randomized clinical trials CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.

M Monami, N Marchionni, E Mannucci - European Journal of …, 2009 - europepmc.org
Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized
clinical trials. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M Monami, N Marchionni, E Mannucci - European Journal of …, 2009 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> The role of glucagon-like peptide-
1 (GLP-1) receptor agonists in the treatment of type 2 diabetes is debated; many recent …
[PDF] psu.edu

[PDF][PDF] GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN TYPE 2 DIABETES: A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS.

M Monami, N Marchionni, E Mannucci, E Mannucci - 2009 - Citeseer
ABSTRACT OBJECTIVE. The role of Glucagon-Like Peptide-1 (GLP-1) receptor agonists in
the treatment of type 2 diabetes is debated; many recent trials, which were not included in …

Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.

M Monami - European Journal of Endocrinology, 2009 - search.ebscohost.com
OBJECTIVE: The role of glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment
of type 2 diabetes is debated; many recent trials, which were not included in previous meta …

[引用][C] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials

M MONAMI - Eur J Endocrinol, 2009 - cir.nii.ac.jp
Glucagon-like peptide-1 receptor agonists in type 2 diabetes : a meta-analysis of
randomized clinical trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …